Insight Talk: Tim Van Hauwermeiren and the success story behind argenx
The Vlerick Award is presented annually by Vlerick Business School as a tribute to successful Vlerick alumni who, as entrepreneurs and business leaders, are at the helm of fast-growing organisations. The 2022 Vlerick Enterprising Leader Award went to Tim Van Hauwermeiren. After successfully completing his Executive MBA at Vlerick 15 years ago, he went on to co-found argenx, now a BEL-20 company with a market cap of around 17 billion euros. During the award show, Dean Marion Debruyne sat down with him for a talk about entrepreneurship and the role that Vlerick played in his journey.

▶︎
Episode 2 - Entrepreneurship through Acquisition in 2022

▶︎
Tim Van Hauwermeiren, argenx CEO: ‘Everyone Can Innovate’

▶︎
Think Fast, Talk Smart: Communication Techniques

▶︎
Moody Gardens Penguin Cam LIVE | Penguin Habitat Stream at the Aquarium in Galveston, Texas

▶︎
TV ART SLIDESHOW 24/7 | Vintage Floral Gallery 🌼4K Framed Art Screensaver for Living Room

▶︎
Most Leaders Don't Even Know the Game They're In | Simon Sinek

▶︎
Inside Anthropic, the $965 Billion AI Juggernaut | The Circuit

▶︎
Philip Kotler: Marketing

▶︎
Episode 1 - Entrepreneurship through Acquisition in 2022

▶︎
Think Faster, Talk Smarter with Matt Abrahams

▶︎
Billionaire's WARNING: I'm SELLING. The Crash Is Already Here!

▶︎
Who Buys Next? Governments Scaling the Carbon Removal Market - Negative Emissions Summit 2026

▶︎
How to Get and Evaluate Startup Ideas | Startup School

▶︎
PCS26 - Which Infrastructures to support New Rules of Engagement in an AI enabled Cyberspace?
![Understand AI in 14 minutes – with Anthropic's Chloe Lubinski [ARC 2026]](https://i.ytimg.com/vi/aBUniZHgCnE/hqdefault.jpg?sqp=-oaymwEjCNACELwBSFryq4qpAxUIARUAAAAAGAElAADIQj0AgKJDeAE=&rs=AOn4CLCyQJdkwlip_867U0IUOY4wCWZJ0g)
▶︎
Understand AI in 14 minutes – with Anthropic's Chloe Lubinski [ARC 2026]

▶︎
The POTScast E123: Argenx Clinical Trial on Post COVID POTS with Drs. van Middendorp & Fedorowsk

▶︎
How to Build a Product that Scales into a Company

▶︎
How to Speak Clearly & With Confidence | Matt Abrahams

▶︎
Risky Biotech Investment: Why Investing in Argenx at the Start was a Home-run

▶︎
